Literature DB >> 25894242

[Type 1 diabetes mellitus. Early detection and prevention].

M Hummel1, P Achenbach.   

Abstract

Type 1 diabetes is the most common autoimmune disease in children and adolescents, with a rising incidence worldwide. Despite improvements in insulin therapy, in many cases complications cannot be avoided and mortality is increased. Therefore, the development of effective prevention strategies is an important medical but also economic goal. Exact prediction of the disease is necessary for prevention studies, and type 1 diabetes can be predicted very accurately with genetic and humoral markers. Primary prevention in genetically predisposed individuals is initiated before diabetes-associated autoantibodies occur. Secondary prevention aims to arrest the progression to type 1 diabetes in autoantibody-positive subjects. Some prevention studies show encouraging results.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25894242     DOI: 10.1007/s00108-014-3626-3

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  29 in total

1.  Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk.

Authors:  V Parikka; K Näntö-Salonen; M Saarinen; T Simell; J Ilonen; H Hyöty; R Veijola; M Knip; O Simell
Journal:  Diabetologia       Date:  2012-03-23       Impact factor: 10.122

2.  Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.

Authors:  Antoinette Moran; Brian Bundy; Dorothy J Becker; Linda A DiMeglio; Stephen E Gitelman; Robin Goland; Carla J Greenbaum; Kevan C Herold; Jennifer B Marks; Philip Raskin; Srinath Sanda; Desmond Schatz; Diane K Wherrett; Darrell M Wilson; Jeffrey P Krischer; Jay S Skyler; Linda Pickersgill; Eelco de Koning; Anette-G Ziegler; Bernhard Böehm; Klaus Badenhoop; Nanette Schloot; Jens Friis Bak; Paolo Pozzilli; Didac Mauricio; Marc Y Donath; Luis Castaño; Ana Wägner; Hans Henrik Lervang; Hans Perrild; Thomas Mandrup-Poulsen
Journal:  Lancet       Date:  2013-04-05       Impact factor: 79.321

3.  Effects of insulin in relatives of patients with type 1 diabetes mellitus.

Authors: 
Journal:  N Engl J Med       Date:  2002-05-30       Impact factor: 91.245

4.  Feature ranking of type 1 diabetes susceptibility genes improves prediction of type 1 diabetes.

Authors:  Christiane Winkler; Jan Krumsiek; Florian Buettner; Christof Angermüller; Eleni Z Giannopoulou; Fabian J Theis; Anette-Gabriele Ziegler; Ezio Bonifacio
Journal:  Diabetologia       Date:  2014-09-04       Impact factor: 10.122

5.  GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.

Authors:  Johnny Ludvigsson; David Krisky; Rosaura Casas; Tadej Battelino; Luis Castaño; James Greening; Olga Kordonouri; Timo Otonkoski; Paolo Pozzilli; Jean-Jacques Robert; Henk J Veeze; Jerry Palmer; Ulf Samuelsson; Helena Elding Larsson; Jan Åman; Gunilla Kärdell; Jan Neiderud Helsingborg; Göran Lundström; Eva Albinsson; Annelie Carlsson; Maria Nordvall; Hans Fors; Carl-Göran Arvidsson; Stig Edvardson; Ragnar Hanås; Karin Larsson; Björn Rathsman; Henrik Forsgren; Helena Desaix; Gun Forsander; Nils-Östen Nilsson; Carl-Göran Åkesson; Päivi Keskinen; Riitta Veijola; Timo Talvitie; Klemens Raile; Thomas Kapellen; Walter Burger; Andreas Neu; Ilse Engelsberger; Bettina Heidtmann; Suzanne Bechtold; David Leslie; Francesco Chiarelli; Alesandro Cicognani; Giuseppe Chiumello; Franco Cerutti; Gian Vincenzo Zuccotti; Ana Gomez Gila; Itxaso Rica; Raquel Barrio; Maria Clemente; Maria José López Garcia; Mercedes Rodriguez; Isabel Gonzalez; Juan Pedro Lopez; Mirentxu Oyarzabal; H M Reeser; Roos Nuboer; Pauline Stouthart; Natasa Bratina; Nina Bratanic; Marc de Kerdanet; Jacques Weill; Nicole Ser; Pascal Barat; Anne Marie Bertrand; Jean-Claude Carel; Rachel Reynaud; Regis Coutant; Sabine Baron
Journal:  N Engl J Med       Date:  2012-02-02       Impact factor: 91.245

6.  Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial.

Authors:  Kirsti Näntö-Salonen; Antti Kupila; Satu Simell; Heli Siljander; Tiina Salonsaari; Anne Hekkala; Sari Korhonen; Risto Erkkola; Jukka I Sipilä; Lotta Haavisto; Marja Siltala; Juhani Tuominen; Jari Hakalax; Heikki Hyöty; Jorma Ilonen; Riitta Veijola; Tuula Simell; Mikael Knip; Olli Simell
Journal:  Lancet       Date:  2008-09-22       Impact factor: 79.321

7.  Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children.

Authors:  P Achenbach; M Hummel; L Thümer; H Boerschmann; D Höfelmann; A G Ziegler
Journal:  Diabetologia       Date:  2013-03-29       Impact factor: 10.122

8.  Brief communication: early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents.

Authors:  Michael Hummel; Ezio Bonifacio; Sandra Schmid; Markus Walter; Annette Knopff; Anette-G Ziegler
Journal:  Ann Intern Med       Date:  2004-06-01       Impact factor: 25.391

9.  Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.

Authors:  Anette G Ziegler; Marian Rewers; Olli Simell; Tuula Simell; Johanna Lempainen; Andrea Steck; Christiane Winkler; Jorma Ilonen; Riitta Veijola; Mikael Knip; Ezio Bonifacio; George S Eisenbarth
Journal:  JAMA       Date:  2013-06-19       Impact factor: 56.272

10.  Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope.

Authors:  Carolin Daniel; Benno Weigmann; Roderick Bronson; Harald von Boehmer
Journal:  J Exp Med       Date:  2011-06-20       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.